What Researchers Did
This study investigated how effective hyperbaric oxygen therapy (HBOT) was for patients with Crohn's disease complications that had not responded to standard medical treatments.
What They Found
Out of 40 patients with refractory Crohn's disease complications, 32 patients (82.5%) achieved complete healing after receiving adjunctive HBOT. Patients with pyoderma gangrenosum showed the highest healing rate at 100%, followed by those with enterocutaneous fistulas at 84.6%, and perianal fistulizing Crohn's disease at 80%.
Canadian Relevance
No direct Canadian connection identified. Crohn's disease complications are not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
This was an observational study, and the abstract notes there is no consensus on the optimal number or duration of HBOT sessions for these conditions.